This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
NEW YORK (Reuters health) – The effects of cardiac resynchronization may be more dramatic in patients with advanced heart failure, but those with less severe symptoms also benefit…
NEW YORK (Reuters Health) – When oral rehydration is problematic, nasogastric administration of fluids is a good alternative for treating dehydrated children in resource-scarce settings, according to a…
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine…
NEW YORK (Reuters Health) – Oral contraceptives are just as effective as a gonadotropin-releasing hormone (GnRH) agonist for relieving pelvic pain due to endometriosis, results of a small…
NEW YORK (Reuters Health) – In a study of newborns with dysplastic and potentially unstable hips, researchers found no difference in radiographic outcome at age 6 between children…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
NEW YORK (Reuters Health) – A new clinical practice guideline from the American College of Physicians recommends strongly against the use of intensive insulin therapy to normalize high…
NEW YORK (Reuters Health) – A D-dimer level below 500 ng/mL reliably rules out acute aortic dissection, although the positive predictive value of a higher concentration is quite…
Ben Wolin, CEO and Co-Founder of Everyday Health, talks about innovations in consumer e-marketing, digital patient care and the future of medicine. Follow Everyday Health on Twitter at:…
NEW YORK (Reuters Health) – The anti-EGFR antibody cetuximab added to two state-of-the-art regimens for metastatic colorectal cancer produces favorable response rates with manageable toxicity, a German team…
